Home >> Industry News >> All The News
frontview no frame frontview vmo3D sideview no frame sideview vmo3D
  • Also available via:

Brien Holden Vision Institute To Launch Institute-owned Commercial Entities PDF
Submit Your News
Australian News
Wednesday, 22 October 2014

Brien Holden Vision Institute recently announced that they are in the process of launching a series of Institute-owned commercial entities known as Brien Holden Vision companies, in Australia, China, India, U.S. and soon, in Europe, to bring to market beneficial, advanced products for myopia and myopia control, presbyopia, and for detection and management of potentially blinding eye disease.

Through collaborations with leading research and industry organisations the Brien Holden Vision Institute works to develop innovative vision correction products for the treatment of the most common eye conditions. It also seeks to apply its vision research more broadly in other medical applications.

"The Brien Holden Vision Institute philosophy has been to develop and license technologies that will improve vision and peoples' lives and from the revenues generated fund programs to develop further outstanding products and deliver affordable, quality vision for everyone…everywhere," says Professor Brien Holden, CEO, Brien Holden Vision Institute. He also says: "The role of the commercial entities that we are establishing is to bring the Institute’s and collaborator-generated product technologies to market. Brien Holden Vision Institute will remain a non-profit, non-commercial, science, translational research, licensing and humanitarian organisation. The Brien Holden Vision subsidiaries, however, are constituted and will be resourced to be successful commercial companies that will support the Institute’s goals through revenue generation and product delivery".

The first major product thrusts from the Institute to the Brien Holden Vision commercial subsidiaries are for myopia and presbyopia. The Institute’s second major product focus category is early detection and management of potentially blinding eye conditions associated with ocular and general health diseases.

Luxury Eyewear Company theo Launches Jewellery Piece PDF
Submit Your News
Product News
Tuesday, 21 October 2014

Hypnotic Jewellery - theoBelgian luxury eyewear designer theo has just announced the introduction of its first jewellery piece, called Hypnotic. Hypnotic is a piece of jewellery that can be worn by anyone who falls under its spell. Whether you're a theo fan, a lover of beautiful objects, a design addict or a fashionista. It's all about making the unwearable wearable. And the object needs to express both the beauty and the individuality that are theo's unique signature.

Hypnotic comes in four different models, two of which are coated in gold and two in palladium. Because of the exclusive character of this striking design, we made a conscious choice to produce it in a limited edition. Only 100 pieces have been made of each model. Each one is numbered on the reverse as well as on the box. And you must admit, the right packaging adds a priceless touch. That's why each one comes individually packed in a 'little black box' with a stylish print. It instantly makes a perfect gift for birthday, Christmas or New Year's.

Smartphone Eye Examination Offers Comparable Results to Traditional Method PDF
Submit Your News
Ophthalmology and Optometry
Monday, 20 October 2014

A smartphone-based tool may be an effective alternative to traditional ophthalmic imaging equipment in evaluating and grading severity of a diabetic eye disease, according to a study released recently at AAO 2014, the American Academy of Ophthalmology's 118th annual meeting. The results of the research indicate the lower-cost method could be useful for bringing the service to patients in isolated or underserved communities.

The traditional method for monitoring the progression of diabetic retinopathy is through retinal slit-lamp biomicroscopy, which enables ophthalmologists to look at the back of the eye's interior. This kind of examination requires a large piece of specialized equipment found only in clinical settings, posing a significant challenge for monitoring patients living in rural or low-resource communities.

In order to find a solution for addressing this challenge, researchers from the University of Brescia, University of Molise and "Federico II" University of Naples, Italy, developed a small optical adapter called D-Eye which could attach magnetically to an iPhone® 5, creating a smartphone ophthalmoscope. They then used the iPhone ophthalmoscope as well as a slit-lamp biomicroscope to perform dilated retinal digital imaging on 120 patients with diabetes who were scheduled to have a routine dilated eye exam. After comparing the results of the smartphone method to the traditional one, an exact agreement between the two methods was found in 85 percent of the eyes and an agreement within one step (or grade of disease progression) was found in 96.7 percent of the eyes. In most of the one- and two-step disagreements, the severity level was graded higher by biomicroscopy grading.

In the smartphone ophthalmoscopy results, nine eyes were not gradable due to small pupil or cataract. In the biomicroscopy results, the number of not gradable images was four. Therefore, while biomicroscopy is still found to be the more accurate method for grading diabetic retinopathy, researchers believe smartphone ophthalmoscopy shows great potential for use in rural or remote communities who would normally receive little to no testing at all.

"Using the iPhone method is thousands of dollars cheaper than using traditional equipment," said lead researcher Andrea Russo, M.D. "The affordability of this option could make it much easier to bring eye care to non-hospital remote or rural settings, which often lack ophthalmic medical personnel."

People with Visual Impairment More Likely Suffer From Multiple Health Conditions PDF
Submit Your News
Ophthalmology and Optometry
Friday, 17 October 2014

Researchers at the University of Glasgow and University of Dundee have found that people with visual impairment are more likely to suffer from multiple health conditions than those without sight problems.

The researchers analysed data provided by the Primary Care Clinical Informatics Unit at the University of Aberdeen for all 1,751,841 registered patients who were alive and permanently registered with 314 Scottish general practices on March 31, 2007. Data on the presence of 29 common chronic physical health conditions, including visual impairment, and eight mental health conditions were extracted. They identified 5,348 – 1.8% of the sample – patients with visual impairment.

They also found that 27 of the 29 physical health conditions and all eight mental health conditions were significantly more likely to be recorded for individuals with visual impairment compared to individuals without visual impairment, after standardising for age, gender and social deprivation. Individuals with visual impairment were also significantly more likely to have more comorbid conditions with 95% of individuals with visual impairment having at least one other health problem compared to 84.5% of the control group. Visually impaired people were significantly more likely to have four or five additional health conditions. 

Dr Court, Research Associate in the Institute of Health and Wellbeing at the University of Glasgow, said: "Our study has important implications for clinical practice and for the future design of integrated services to meet the complex needs of patients with visual impairment, such as embedding depression and hearing screening within eye care services".

The findings have been published in the journal BMC Medicine.

Marchon To Launch New ETRO EYEWEAR Collection PDF
Submit Your News
Thursday, 16 October 2014

Etro EyewearMarchon Eyewear has announced the launch of the new ETRO EYEWEAR collection, beginning in September 2015.

Etro and Marchon signed an exclusive licensing agreement to design, manufacture and distribute the sun and ophthalmic collections ETRO EYEWEAR. The partnership aims to further increase the already significant position of Etro in the accessories world.

"It's a significant debut that represents for us a new challenge, and that gives us new energy. It comes from the need of completeness: The creation of an eyewear line is a further step in our creative and stylistic path, which contributes to the strengthening of our brand identity and heritage," stated Jacopo Etro, Creative Director of the Etro Accessories collections.

Claudio Gottardi, Marchon Eyewear President and CEO, commented: "The global licensing agreement with Etro represents Marchon’s strategic goals to expand our portfolio with compelling European luxury brands. The team at our Italian Design and Product Development Center will work in collaboration with Etro’s designers to interpret and translate the strong identity of the fashion house, including the iconic paisley motif, in order to conceive sophisticated eyewear collections featuring the high quality of ‘Made in Italy’ manufacturing.”

The ETRO EYEWEAR collection, 100% Made in Italy as every Etro collection, will be available starting September 2015 in Etro boutiques, renowned department stores, and select optical and specialty stores worldwide.

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 1 of 290